<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         dtd-version="1.1"
         xml:lang="sl"
         article-type="other">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="nlm-ta">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="doi">Zdrav Vestn</journal-id>
         <journal-title-group>
            <journal-title>Zdravniški vestnik</journal-title>
            <trans-title-group xml:lang="en">
               <trans-title>Slovenian Medical Journal</trans-title>
            </trans-title-group>
            <abbrev-journal-title>Zdrav Vestn</abbrev-journal-title>
         </journal-title-group>
         <issn publication-format="ppub" pub-type="ppub">1318-0347</issn>
         <issn publication-format="epub" pub-type="epub">1581-0224</issn>
         <issn-l>0350-0063</issn-l>
         <publisher>
            <publisher-name xml:lang="sl">Slovensko zdravniško društvo</publisher-name>
            <publisher-name xml:lang="en">Slovenian Medical Association</publisher-name>
            <publisher-loc xml:lang="sl">Ljubljana, Slovenia</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.6016/ZdravVestn.2702</article-id>
         <article-id pub-id-type="publisher-id">2702</article-id>
         <article-categories>
            <subj-group subj-group-type="discipline" xml:lang="en">
               <subject>Medicine and health sciences</subject>
               <subj-group>
                  <subject>Metabolic and hormonal disorders Professional article</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="discipline" xml:lang="sl">
               <subject>Medicina/Zdravstvo</subject>
               <subj-group>
                  <subject>Metabolne in hormonske motnje Strokovni članek</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="en">
               <subject/>
            </subj-group>
            <subj-group subj-group-type="heading" xml:lang="sl">
               <subject>Metabolne in hormonske motnje Strokovni članek</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title xml:lang="sl">Alergijski rinitis in njegov vpliv na astmo (ARIA) – glavni povzetek 2016: Integrirane klinične poti za napovedno medicino v vseh življenjskih obdobjih</article-title>
            <trans-title-group>
               <trans-title xml:lang="en">ARIA 2016 Executive Summary: Integrated care pathways for predictive medicine across the life cycle</trans-title>
            </trans-title-group>
            <alt-title alt-title-type="running-head" xml:lang="sl">Alergijski rinitis in njegov vpliv na astmo (ARIA)</alt-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Zidarn</surname>
                  <given-names>Mihaela</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="aff" rid="aff2">2</xref>
               <xref ref-type="corresp" rid="corr"/>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bajrović</surname>
                  <given-names>Nissera</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Jenko</surname>
                  <given-names>Klemen</given-names>
               </name>
               <xref ref-type="aff" rid="aff2">2</xref>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Kopač</surname>
                  <given-names>Peter</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Košnik</surname>
                  <given-names>Mitja</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="aff" rid="aff2">2</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Edelbaher</surname>
                  <given-names>Natalija</given-names>
               </name>
               <xref ref-type="aff" rid="aff4">4</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Jošt</surname>
                  <given-names>Maja</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Kramer Vrščaj</surname>
                  <given-names>Karmen</given-names>
               </name>
               <xref ref-type="aff" rid="aff5">5</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Koren Jeverica</surname>
                  <given-names>Anja</given-names>
               </name>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Kreft</surname>
                  <given-names>Samo</given-names>
               </name>
               <xref ref-type="aff" rid="aff6">6</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Lalek</surname>
                  <given-names>Nika</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="aff" rid="aff7">7</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Madjar</surname>
                  <given-names>Bojan</given-names>
               </name>
               <xref ref-type="aff" rid="aff8">8</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Poplas Susič</surname>
                  <given-names>Antonija</given-names>
               </name>
               <xref ref-type="aff" rid="aff2">2</xref>
               <xref ref-type="aff" rid="aff9">9</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Rozman Sinur</surname>
                  <given-names>Irma</given-names>
               </name>
               <xref ref-type="aff" rid="aff10">10</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Soklič Košak</surname>
                  <given-names>Tanja</given-names>
               </name>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Triller</surname>
                  <given-names>Katja</given-names>
               </name>
               <xref ref-type="aff" rid="aff11">11</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Triller</surname>
                  <given-names>Nadja</given-names>
               </name>
               <xref ref-type="aff" rid="aff12">12</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Urbančič</surname>
                  <given-names>Jure</given-names>
               </name>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Agache</surname>
                  <given-names>Ioana</given-names>
               </name>
               <xref ref-type="aff" rid="aff13">13</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bachert</surname>
                  <given-names>Claus</given-names>
               </name>
               <xref ref-type="aff" rid="aff14">14</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bedbrook</surname>
                  <given-names>Anna</given-names>
               </name>
               <xref ref-type="aff" rid="aff15">15</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Canonica</surname>
                  <given-names>Giorgio Walter</given-names>
               </name>
               <xref ref-type="aff" rid="aff16">16</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Casale</surname>
                  <given-names>Thomas</given-names>
               </name>
               <xref ref-type="aff" rid="aff17">17</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Cruz</surname>
                  <given-names>Alvaro A</given-names>
               </name>
               <xref ref-type="aff" rid="aff18">18</xref>
               <xref ref-type="aff" rid="aff19">19</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Fokkens</surname>
                  <given-names>Wytske J</given-names>
               </name>
               <xref ref-type="aff" rid="aff20">20</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Hellings</surname>
                  <given-names>Peter W</given-names>
               </name>
               <xref ref-type="aff" rid="aff21">21</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Samolinski</surname>
                  <given-names>Boleslaw</given-names>
               </name>
               <xref ref-type="aff" rid="aff22">22</xref>
               <xref ref-type="aff" rid="aff23">23</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bousquet</surname>
                  <given-names>Jean</given-names>
               </name>
               <xref ref-type="aff" rid="aff15">15</xref>
            </contrib>
         </contrib-group>
         <aff-alternatives id="aff1">
            <aff xml:lang="sl">
               <label>1</label>
               <institution>Univerzitetna Klinika za pljučne bolezni in alergijo Golnik, Golnik, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>1</label>
               <institution>University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff2">
            <aff xml:lang="sl">
               <label>2</label>
               <institution>Medicinska fakulteta, Univerza v Ljubljani, Ljubljana, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>2</label>
               <institution>Faculty of medicine, University of Ljubljana, Ljubljana, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff3">
            <aff xml:lang="sl">
               <label>3</label>
               <institution>Univerzitetni klinični center Ljubljana, Ljubljana, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>3</label>
               <institution>University Medical Centre Ljubljana, Ljubljana, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff4">
            <aff xml:lang="sl">
               <label>4</label>
               <institution>Univerzitetni klinični center Maribor, Maribor, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>4</label>
               <institution>University Medical Centre Maribor, Maribor, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff5">
            <aff xml:lang="sl">
               <label>5</label>
               <institution>Internistična ambulanta za pljučne in alergijske bolezni Celje, Celje, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>5</label>
               <institution>Internistična ambulanta za pljučne in alergijske bolezni Celje, Celje, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff6">
            <aff xml:lang="sl">
               <label>6</label>
               <institution>Fakulteta za farmacijo, Univerza v Ljubljani, Ljubljana, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>6</label>
               <institution>Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff7">
            <aff xml:lang="sl">
               <label>7</label>
               <institution>Bolnišnica Topolščica, Topolščica, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>7</label>
               <institution>Hospital Topolščica, Topolščica, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff8">
            <aff xml:lang="sl">
               <label>8</label>
               <institution>Pomurske lekarne Lekarna Puconci, Puconci, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>8</label>
               <institution>Pomurske lekarne Lekarna Puconci, Puconci, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff9">
            <aff xml:lang="sl">
               <label>9</label>
               <institution>Zdravstveni dom Ljubljana, Ljubljana, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>9</label>
               <institution>Community health centre Ljubljana, Ljubljana, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff10">
            <aff xml:lang="sl">
               <label>10</label>
               <institution>Splošna bolnišnica Novo Mesto, Novo Mesto, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>10</label>
               <institution>General hospital Novo Mesto, Novo Mesto, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff11">
            <aff xml:lang="sl">
               <label>11</label>
               <institution>Splošna Bolnišnica Izola, Izola, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>11</label>
               <institution>Izola General hospital, Izola, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff12">
            <aff xml:lang="sl">
               <label>12</label>
               <institution>Zdravstveni dom Murska Sobota, Murska Sobota, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>12</label>
               <institution>Community health centre Murska Sobota, Murska Sobota, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff13">
            <aff xml:lang="sl">
               <label>13</label>
               <institution>Faculty of Medicine, Transylvania University, Brasov, Romunija</institution>
            </aff>
            <aff xml:lang="en">
               <label>13</label>
               <institution>Faculty of Medicine, Transylvania University, Brasov, Romania</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff14">
            <aff xml:lang="sl">
               <label>14</label>
               <institution>Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgija</institution>
            </aff>
            <aff xml:lang="en">
               <label>14</label>
               <institution>Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff15">
            <aff xml:lang="sl">
               <label>15</label>
               <institution>MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, Francija</institution>
            </aff>
            <aff xml:lang="en">
               <label>15</label>
               <institution>MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff16">
            <aff xml:lang="sl">
               <label>16</label>
               <institution>Personalized Medicine Clinic Asthma &amp; Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan, Italija</institution>
            </aff>
            <aff xml:lang="en">
               <label>16</label>
               <institution>Personalized Medicine Clinic Asthma &amp; Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan, Italy</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff17">
            <aff xml:lang="sl">
               <label>17</label>
               <institution>Division of Allergy/Immunology, University of South Florida, Tampa, ZDA</institution>
            </aff>
            <aff xml:lang="en">
               <label>17</label>
               <institution>Division of Allergy/Immunology, University of South Florida, Tampa, USA</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff18">
            <aff xml:lang="sl">
               <label>18</label>
               <institution>ProAR – Nucleo de Excelencia em Asma, Federal University of Bahia, GARD/WHO Executive Committee and Federal University of Bahia, Brazilija</institution>
            </aff>
            <aff xml:lang="en">
               <label>18</label>
               <institution>ProAR – Nucleo de Excelencia em Asma, Federal University of Bahia, GARD/WHO Executive Committee and Federal University of Bahia, Brasil</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff19">
            <aff xml:lang="sl">
               <label>19</label>
               <institution>GARD/WHO Executive Committee and Federal University of Bahia, Braziilija</institution>
            </aff>
            <aff xml:lang="en">
               <label>19</label>
               <institution>GARD/WHO Executive Committee and Federal University of Bahia, Brasil</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff20">
            <aff xml:lang="sl">
               <label>20</label>
               <institution>Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, Nizozemska</institution>
            </aff>
            <aff xml:lang="en">
               <label>20</label>
               <institution>Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, Netherlands</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff21">
            <aff xml:lang="sl">
               <label>21</label>
               <institution>Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgija</institution>
            </aff>
            <aff xml:lang="en">
               <label>21</label>
               <institution>Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff22">
            <aff xml:lang="sl">
               <label>22</label>
               <institution>Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Poljska</institution>
            </aff>
            <aff xml:lang="en">
               <label>22</label>
               <institution>Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Poland</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff23">
            <aff xml:lang="sl">
               <label>23</label>
               <institution>VIMA. INSERM U 1168, VIMA: Ageing and chronic diseases, Epidemiological and public health approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, Francija</institution>
            </aff>
            <aff xml:lang="en">
               <label>23</label>
               <institution>VIMA. INSERM U 1168, VIMA: Ageing and chronic diseases, Epidemiological and public health approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France</institution>
            </aff>
         </aff-alternatives>
         <author-notes>
            <fn fn-type="conflict" xml:lang="en">
               <p>The authors have declared that no competing interests exist.</p>
            </fn>
            <fn fn-type="conflict" xml:lang="sl">
               <p>Avtorji so izjavili, da ne obstajajo nobeni konkurenčni interesi.</p>
            </fn>
            <corresp id="corr">Mihaela Zidarn, e-mail: <email xlink:type="simple"/>
            </corresp>
         </author-notes>
         <pub-date pub-type="ppub">
            <month>6</month>
            <year>2019</year>
         </pub-date>
         <pub-date pub-type="epub">
            <month>6</month>
            <year>2019</year>
         </pub-date>
         <volume>88</volume>
         <issue>5–6</issue>
         <fpage>291</fpage>
         <lpage>301</lpage>
         <history>
            <date date-type="received">
               <day>19</day>
               <month>1</month>
               <year>2018</year>
            </date>
            <date date-type="accepted">
               <day>15</day>
               <month>4</month>
               <year>2019</year>
            </date>
         </history>
         <permissions>
            <copyright-statement xml:lang="en">Copyright © 2019, Slovenian Medical Association (SZD)</copyright-statement>
            <copyright-statement xml:lang="sl">© 2019, Slovensko zdravniško društvo (SZD)</copyright-statement>
            <copyright-year>2019</copyright-year>
            <copyright-holder xml:lang="en">Slovenian Medical Association (SZD)</copyright-holder>
            <copyright-holder xml:lang="sl">Slovensko zdravniško društvo (SZD)</copyright-holder>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="en">
               <license-p>This is an open access article distributed under the terms of the
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Attribution-NonCommercial
            License</ext-link>, which permits unrestricted use, distribution, and
          reproduction in any medium, provided the original author and source are
          credited and only for non-commercial purposes. </license-p>
            </license>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="sl">
               <license-p>To je članek z odprtim dostopom, ki ga lahko uporabite pod pogoji iz
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Priznanje avtorstva-Nekomercialno
            licence</ext-link>. ki dovoljuje distribucijo, predelavo ali
          prilagoditev, ter gradijo na njem, v nekomercialne namene, z navedbo avtorja
          in izvirnega dela.</license-p>
            </license>
         </permissions>
         <abstract xml:lang="sl">
            <title>Izvleček</title>
            <p>Pobudo »Alergijski rinitis in njegov vpliv na astmo« – (<italic>angl.</italic> Allergic Rhinitis and its Impact on Asthma, ARIA) – so leta 1999 ustanovili na delavnici Svetovne zdravstvene organizacije – World Health Organization (WHO). Njeni prvotni cilji so bili: 1. predlagati novo klasifikacijo alergijskega rinitisa, 2. spodbujati koncept večobolevnosti pri astmi in rinitisu ter 3. skupaj z vsemi deležniki razviti smernice, namenjene globalni uporabi v vseh državah in vsem skupinam bolnikov. Pobuda ARIA se uporablja v 70 državah, trenutno pa se osredinja na uporabo novih tehnologij za individualizirano in napovedno medicino. Mreža MASK – nadzorna mreža MACVIA (Proti kroničnim boleznim za aktivno staranje, <italic>franc.</italic> – Contre les Maladies Chroniques pour un Vieillissement Actif) in ARIA (<italic>angl.</italic> ARIA Sentinel NetworK) uporablja mobilno tehnologijo za razvoj klinične poti, ki bi bolnikom, multidisciplinarnim ekipam zdravnikov in raziskovalcem omogočila nadzor rinitisa in astme. Mobilna aplikacija (Android in iOS) je na voljo v 20 državah in 15 jezikih. Uporablja vizualno analogno lestvico za oceno nadzora nad simptomi in oceno delovne zmožnosti in ponuja sistem, ki pomaga pri kliničnem odločanju. Aplikacija omogoča povezovanje z zdravnikom ali drugimi zdravstvenimi delavci. Ta strategija upošteva priporočila Evropskega partnerstva za inovacije za aktivno in zdravo staranje (<italic>angl.</italic> European Innovation Partnership on Active and Healthy Ageing, EIP on AHA). Cilj novega pristopa pobude ARIA je zagotoviti aktivno in zdravo življenje bolnikov z rinitisom ne glede na njihovo starost, spol ali družbenogospodarski položaj zato, da bi se zmanjšali zdravstvena in družbena neenakost, ki sta posledici te bolezni.</p>
         </abstract>
         <trans-abstract xml:lang="en">
            <title>Abstract</title>
            <p>The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization (WHO) workshop in 1999. The initial goals were (i) to propose a new allergic rhinitis classification, (ii) to promote the concept of multi-morbidity in asthma and rhinitis and (iii) to develop guidelines with all stakeholders for global use in all countries and populations. ARIA - disseminated and implemented in over 70 countries globally - is now focusing on the implementation of emerging technologies for individualised and predictive medicine. MASK (MACVIA (<italic>Contre les MAladies Chroniques pour un VIeillissement Actif</italic>)-ARIA Sentinel NetworK) uses mobile technology to develop care pathways in order to enable the management of rhinitis and asthma by a multi-disciplinary group or by patients themselves. An App (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.</p>
         </trans-abstract>
         <kwd-group xml:lang="sl">
            <kwd>alergijski rinitis</kwd>
            <kwd>astma</kwd>
            <kwd>integrirana klinična pot</kwd>
            <kwd>mobilna tehnologija</kwd>
            <kwd>bolezni dihalnih poti</kwd>
         </kwd-group>
         <kwd-group xml:lang="en">
            <kwd>allergic rhinitis;asthma</kwd>
            <kwd>integrated care pathway</kwd>
            <kwd>mobile technology</kwd>
            <kwd>airway diseases</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="Uvod">
         <label>1</label>
         <title>Uvod</title>
         <p>Bolniki, zdravniki in drugi zdravstveni delavci imajo na voljo različne možnosti zdravljenja alergijskega rinitisa (AR). Zato je klinična praksa zelo pestra, bolniki pa pogosto niso zadovoljni z obravnavo. Pobuda »Alergijski rinitis in njegov vpliv na astmo« (<italic>angl.</italic>
            <italic> </italic>Allergic Rinitis and its Impact on Asthma, ARIA) je bila ustanovljena leta 1999 na delavnici WHO (objavljena leta 2001). Z njo so želeli zagotoviti smernice za diagnosticiranje in obravnavanje hkratne prisotnosti alergijskega rinitisa in astme (<xref ref-type="bibr" rid="b1">1</xref>,<xref ref-type="bibr" rid="b2">2</xref>). Pobuda ARIA je bila leta 2008 posodobljena (<xref ref-type="bibr" rid="b1">1</xref>,<xref ref-type="bibr" rid="b3">3</xref>). V reviziji iz leta 2010 so se v okviru nje oblikovale prve smernice za kronične pljučne bolezni, ki uporabljajo napredno metodologijo za ocenjevanje dokazov, razvrščanje priporočil, ocenjevanje, razvoj in vrednotenje (<italic>angl.</italic> Grading of Recommendation, Assessment, Development and Evaluation, GRADE) (<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b5">5</xref>).</p>
         <p>Pobuda ARIA, ki je razširjena in se uporablja v 70 državah, se zdaj usmerja k uporabi novih tehnologij za individualizirano in napovedno medicino. Mreža MASK uporablja mobilno tehnologijo za razvoj kliničnih poti, ki bi multidisciplinarnim skupinam ali bolnikom omogočila nadzor rinitisa in astme (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b8">8</xref>).</p>
         <p>Cilj novega pristopa v okviru pobude ARIA je zagotoviti aktivno in zdravo življenje bolnikom z rinitisom, in sicer ne glede na njihovo starost, spol ali družbeno-gospodarski položaj, da bi se zmanjšali zdravstvena in družbena neenakost, do katerih pride zaradi te bolezni.</p>
         <p>Članek je decembra 2016 objavila revija Clinical and Translational Allergy.</p>
         <p>S prevodom članka v slovenščino želimo v slovenskem okolju predstaviti novost vodenja bolnikov s kronično boleznijo s pomočjo sodobne tehnologije, ki omogoča sodelovanje vseh vključenih v ta proces, od farmacevtov v lekarnah do splošnih zdravnikov in specialistov.</p>
      </sec>
      <sec id="s2"
           sec-type="Integrirane klinične poti za bolezni dihalnih poti (angl. Integrated care pathways for airway diseases, AIRWAYS ICPs): prednostne naloge pobude ARIA 2016">
         <label>2</label>
         <title>Integrirane klinične poti za bolezni dihalnih poti (angl. Integrated care pathways for airway diseases, AIRWAYS ICPs): prednostne naloge pobude ARIA 2016</title>
         <p>Evropska komisija je leta 2012 ustanovila Evropsko partnerstvo za inovacije za aktivno in zdravo staranje (<italic>angl.</italic> European Innovation Partnership on Active and Healthy Ageing, EPI on AHA). Namena tega sta bila okrepitev konkurenčnosti Evropske unije ter reševanje družbenih izzivov staranja z raziskavami in inovacijami (<xref ref-type="bibr" rid="b9">9</xref>). Akcijski načrt B3 je namenjen pospeševanju in dopolnjevanju uspešnih inovativnih integriranih modelov oskrbe kroničnih bolezni pri odraslih. Za pilotni projekt so izbrali kronične bolezni dihalnih poti.</p>
         <p>AIRWAYS ICPs je implementacijsko orodje projekta EPI on AHA. Glavna dejavnost AIRWAYS ICP je razvoj večsektorskih poti oskrbe (<italic>angl.</italic>Intergrated care pathways, ICP) – rinitisa, astme in pridruženih bolezni z uporabo novih tehnologij napovedne medicine v vseh življenjskih obdobjih bolnikov (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b10">10</xref>). Cilja sta zmanjšanje bremena kroničnih bolezni dihal, umrljivosti in polimorbidnosti in vzdrževanje kakovosti življenja bolnikov (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b11">11</xref>). Akcijski načrt AIRWAYS ICPs se je udejanil in razširil na globalni ravni (<xref ref-type="bibr" rid="b12">12</xref>), hkrati pa je vzorčni projekt Globalnega združenja za boj proti kroničnim boleznim dihal WHO (<italic>angl.</italic> World health organisation Global Alliance against Chronic Respiratory Diseases, WHO GARD) (<xref ref-type="fig" rid="fig1">Slika 1</xref>). ARIA 2016 je pomemben del AIRWAYS ICPs (<xref ref-type="bibr" rid="b13">13</xref>).</p>
         <fig position="anchor" id="fig1">
            <label>Slika 1:</label>
            <caption>
               <p> Povezave med AIRWAYS ICPs, Evropsko unijo in WHO (povzeto po Bousquet et al) (<xref ref-type="bibr" rid="b11">11</xref>).</p>
            </caption>
            <p>
               <graphic xlink:href="2702-web-resources/image/zdravvestn-2702-sl-01.png"/>
            </p>
            <p>NGO: nongovernmental organisation – nevladne organizacije; GO: Governmental organisation – vladne organizacije; MOH: Ministry of Health – ministrstvo za zdravje; WHO GARD World health organisation Global Alliance against Chronic Respiratory Diseases – Globalno združenje Svetovne zdravstvene organizacije za boj proti kroničnim boleznim dihal; NCD: Non-communicable disease – neprenosljive bolezni; DG: Directorate General – generalni direktorat; DG Sante: Directorate-General for Health and Food Safety – generalni direktorat za zdravje in varnost hrane; DG CONNECT: The DirectorateGeneral for Communications Networks, Content and Technology – generalni direktorat za komunikacijska omrežja, vsebine in tehnologijo; DG Research: Directorate General for Research and inovation – generalni direktorat za razvoj in inovacije; AIRWAYS ICPs: Integrated care pathways for airway disease – integrirane klinične poti za bolezni dihalnih poti; EIP on AHA: European Innovation Partnership on Active and Healthy Ageing – Evropsko partnerstvo za inovacije za aktivno in zdravo staranje.</p>
         </fig>
      </sec>
      <sec id="s3"
           sec-type="Od smernic do integriranih kliničnih poti: mreža MASK">
         <label>3</label>
         <title>Od smernic do integriranih kliničnih poti: mreža MASK</title>
         <sec id="s3.1"
              sec-type="Potreba po večsektorskih kliničnih poteh za rinitis in astmo z uporabo ICP">
            <label>3.1</label>
            <title>Potreba po večsektorskih kliničnih poteh za rinitis in astmo z uporabo ICP</title>
            <p>Bolniki z AR se pogosto zdravijo sami. Redko se posvetujejo glede uporabe zdravil za AR (<xref ref-type="bibr" rid="b14">14</xref>), čeprav to negativno vpliva na številne življenjske dejavnosti – družabno življenje, šolski uspeh in delovno zmožnost (<xref ref-type="bibr" rid="b3">3</xref>). Veliko bolnikov z AR uporablja zdravila, ki so na voljo brez recepta (<xref ref-type="bibr" rid="b15">15</xref>-<xref ref-type="bibr" rid="b17">17</xref>), le redki se o njih posvetujejo z zdravnikom. Večina bolnikov, ki obiščejo osebnega zdravnika ali specialista, ima zmeren do težak rinitis (<xref ref-type="bibr" rid="b18">18</xref>-<xref ref-type="bibr" rid="b20">20</xref>). Bolnikom je na voljo več različnih zdravil (na recept ali brez tega), možnost specifične imunoterapije ali izbira alternativne medicine (<xref ref-type="bibr" rid="b21">21</xref>). Tako naj bi po priporočilih AIRWAYS ICPs integrirane klinične poti upoštevale multidisciplinarni pristop, vključno s samozdravljenjem (<xref ref-type="fig" rid="fig2">Slika 2</xref>).</p>
            <fig position="anchor" id="fig2">
               <label>Slika 2:</label>
               <caption>
                  <p> Multisektorska pot oskrbe alergijskega rinitisa (povzeto po Bosquet et al) (<xref ref-type="bibr" rid="b25">25</xref>).</p>
               </caption>
               <p>
                  <graphic xlink:href="2702-web-resources/image/zdravvestn-2702-sl-02.png"/>
               </p>
            </fig>
            <p>ICP so strukturirani multidisciplinarni načrti oskrbe, ki določajo ključne korake pri oskrbi bolnikov. Spodbujajo prenos smernic v lokalne protokole in njihovo uporabo v klinični praksi. ICP se razlikujejo od kliničnih smernic, saj jih uporabljajo multidisciplinarne ekipe, osredinjajo pa se na kakovost in koordinacijo oskrbe. ICP morajo imeti mehanizem za evidentiranje sprememb oz. odstopanj od načrtovane oskrbe.</p>
            <p>Variacije ali deviacije od priporočenega zdravljenja po smernicah pobude ARIA so natančno proučili. Stopnja bolezni je povezana z različnimi dejavniki zdravja in tudi s kakovostjo življenja (<xref ref-type="bibr" rid="b18">18</xref>-<xref ref-type="bibr" rid="b20">20</xref>). Klasifikacija rinitisa (občasen, trajen; lahek oz. zmeren, težak) je v nekaterih raziskavah (<xref ref-type="bibr" rid="b22">22</xref>) pomemben kazalnik pridružene astme, enako velja za trajanje in učinkovitost zdravljenja AR (<xref ref-type="bibr" rid="b23">23</xref>). Večina bolnikov z AR prejema kombinacije peroralnih antihistaminikov in nosnih glukokortikoidov, ki pa v smernicah, ki uporabljajo primerno metodologijo, niso ustrezno ovrednotene (<xref ref-type="bibr" rid="b24">24</xref>).</p>
         </sec>
         <sec id="s3.2"
              sec-type="Preprost pristop ocenjevanja nadzora alergijskega rinitisa">
            <label>3.2</label>
            <title>Preprost pristop ocenjevanja nadzora alergijskega rinitisa</title>
            <p>Po smernicah pobude ARIA je vodilo zdravljenja nadzor nad boleznijo in ne teža simptomov. Orodja so:</p>
            <list>
               <list-item>
                  <label>1.</label>
                  <p>vizualna analogna lestvica (<italic>angl.</italic> visual analogue scale, VAS) – kot ovrednoten način nadzora AR,</p>
               </list-item>
               <list-item>
                  <label>2.</label>
                  <p>razvrstitev nadzora AR na podlagi mejnih vrednosti VAS,</p>
               </list-item>
               <list-item>
                  <label>3.</label>
                  <p>vključitev vizualne analogne lestvice v preproste interaktivne aplikacije za bolnika (alergijski dnevnik ARIA) in zdravstvene delavce (spremljevalec alergijskega dnevnika ARIA) (<xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>),</p>
               </list-item>
               <list-item>
                  <label>4.</label>
                  <p>integracija tega znanja v ICP (<xref ref-type="bibr" rid="b25">25</xref>) in</p>
               </list-item>
               <list-item>
                  <label>5.</label>
                  <p>razvoj sistemov, ki pomagajo pri kliničnih odločitvah (<italic>angl.</italic> clinical decision support system, CDSS).</p>
               </list-item>
            </list>
            <p>Simptomi AR se spreminjajo iz dneva v dan in zahtevajo povečevanje ali zmanjševanje individualiziranih terapevtskih odmerkov. Bolniki, skrbniki ali izvajalci zdravstvene dejavnosti bi morali uporabljati skupni in preprost sistem za točkovanje simptomov AR, ki se hitro odziva na spremembe. Nadzorna mreža MACVIA-ARIA prinaša preprost algoritem ARIA CDSS, ki temelji na VAS in uporablja rezultat VAS kot usmeritev pri nadaljnjih terapevtskih spremembah, torej pri zmanjševanju oz. povečevanju odmerkov (<xref ref-type="bibr" rid="b27">27</xref>). Splošni zdravnik ali specialist na podlagi podatkov iz bolnikovega alergijskega dnevnika ARIA, do katerega dostopa s pomočjo spremljevalca alergijskega dnevnika ARIA, prilagodi terapevtski nasvet s pomočjo algoritma ARIA CDSS.</p>
         </sec>
         <sec id="s3.3"
              sec-type="Orodja MASK: aplikaciji »alergijski dnevnik ARIA« in »spremljevalec alergijskega dnevnika ARIA«">
            <label>3.3</label>
            <title>Orodja MASK: aplikaciji »alergijski dnevnik ARIA« in »spremljevalec alergijskega dnevnika ARIA«</title>
            <p>Aplikaciji »alergijski dnevnik ARIA« in »spremljevalec alergijskega dnevnika ARIA« (<xref ref-type="bibr" rid="b26">26</xref>) sta bolnikom in zdravstvenim delavcem prosto dostopni v 15 državah EU, Avstraliji, Braziliji, Kanadi, Mehiki in Švici. Na voljo sta v 15 jezikih (prevod iz angleščine v druge ciljne jezike, kulturno prilagojen in v skladu z lokalnimi pravnimi predpisi) in trenutno še nista prevedeni v slovenščino.</p>
            <sec id="s3.3.1" sec-type="Vprašalniki">
               <label>3.3.1</label>
               <title>Vprašalniki</title>
               <p>Uporabnik ob registraciji »alergijskega dnevnika ARIA« izpolni preproste vprašalnike glede astme, rinitisa in vpliva bolezni (na splošno počutje, delo, šolski uspeh, dnevne dejavnosti in spanje) (<xref ref-type="table" rid="table1">Tabela 1</xref>). Pilotna študija, v katero je bilo vključenih okoli 5.000 uporabnikov (9 % starejših od 60 let), je pokazala, da na vprašanja ni težko odgovoriti in da pomagajo pri stratifikaciji bolnikov z rinitisom (<xref ref-type="bibr" rid="b28">28</xref>). Poleg tega bolnik tedensko izpolnjuje posebna vprašalnika, ki pomagata oceniti vpliv bolezni na kakovost njegovega življenja (<xref ref-type="bibr" rid="b29">29</xref>) in njegovo zmožnost pri delu (<xref ref-type="bibr" rid="b30">30</xref>).</p>
               <table-wrap position="anchor" id="table1">
                  <label>Tabela 1:</label>
                  <caption>
                     <p> Osnovni vprašalniki.</p>
                  </caption>
                  <table>
                     <colgroup>
                        <col/>
                     </colgroup>
                     <tbody>
                        <tr>
                           <th content-type="table-subhead">V1: Imam rinitis?: DA/NE</th>
                        </tr>
                        <tr>
                           <th content-type="table-subhead">V2: Imam astmo?: DA/NE</th>
                        </tr>
                        <tr>
                           <th content-type="table-subhead">V3: Moji simptomi (izberi):</th>
                        </tr>
                        <tr>
                           <td>
                              <p>•izcedek iz nosu</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•srbeč nos</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•kihanje</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•nosna kongestija (zamašen nos)</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•pordele oči</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•srbeče oči</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•solzne oči</p>
                           </td>
                        </tr>
                        <tr>
                           <th content-type="table-subhead">V4: Kako simptomi vplivajo name? (izberi):</th>
                        </tr>
                        <tr>
                           <td>
                              <p>•vplivajo na moj spanec</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•omejujejo moje dnevne dejavnosti</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•omejujejo moje sodelovanje v šoli ali službi</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•so moteči</p>
                           </td>
                        </tr>
                        <tr>
                           <th content-type="table-subhead">V5: Zdravila</th>
                        </tr>
                        <tr>
                           <th content-type="table-subhead">V6: Ali trenutno prejemate imunoterapijo (injekcija ali dajate pod jezik majhne odmerke snovi, na katero ste alergični)? DA/NE</th>
                        </tr>
                        <tr>
                           <td>Če ste na vprašanje V6 odgovorili z DA, odgovorite tudi na V7 in V8.</td>
                        </tr>
                        <tr>
                           <th content-type="table-subhead">V7: Za kateri alergen gre?</th>
                        </tr>
                        <tr>
                           <td>
                              <p>•cvetni prah trav</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•cvetni prah krišine</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•cvetni prah breze</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•drug cvetni prah</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•pršice</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•živali</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•cvetni prah ciprese</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•ne vem</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•dodaj alergen</p>
                           </td>
                        </tr>
                        <tr>
                           <th content-type="table-subhead">V8: Kako prejemate zdravljenje?</th>
                        </tr>
                        <tr>
                           <td>
                              <p>•injekcija</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•tableta pod jezik</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•kapljice pod jezik</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•razpršilo pod jezik</p>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <p>•drugo</p>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </table-wrap>
            </sec>
            <sec id="s3.3.2" sec-type="Zdravljenje">
               <label>3.3.2</label>
               <title>Zdravljenje</title>
               <p>V »alergijski dnevnik ARIA« je vključen seznam vseh oblik zdravljenja astme, konjuktivitisa in rinitisa. Uporabnik izbere zdravljenje, pri čemer se lahko odloči za različne možnosti in v primeru spremembe posodobi informacije (<xref ref-type="fig" rid="fig3">Slika 3</xref>). Seznam je bil prilagojen za vseh 20 držav, v katerih je na voljo »alergijski dnevnik ARIA«. Prvi dan uporabe bolnik vnese tudi informacije o morebitni specifični imunoterapiji z alergeni.</p>
               <fig position="anchor" id="fig3">
                  <label>Slika 3:</label>
                  <caption>
                     <p> Prikaz zavihka z zdravili.</p>
                  </caption>
                  <p>
                     <graphic xlink:href="2702-web-resources/image/zdravvestn-2702-sl-03.jpg"/>
                  </p>
               </fig>
            </sec>
            <sec id="s3.3.3" sec-type="Dnevne vizualne analogne lestvice">
               <label>3.3.3</label>
               <title>Dnevne vizualne analogne lestvice</title>
               <p>Uporabnik, ki ga aplikacija tudi krajevno umesti, vsak dan prek pametnega telefona oceni simptome AR tako, da klikne na pet zaporednih vizualnih analognih lestvic (splošni simptomi zaradi alergijske bolezni, rinitis, konjunktivitis, astma in delovna zmožnost) (<xref ref-type="fig" rid="fig4">Slika 4</xref>).</p>
               <fig position="anchor" id="fig4">
                  <label>Slika 4:</label>
                  <caption>
                     <p> Prikaz zavihka z zdravili z vizualnimi analognimi lestvicami.</p>
                  </caption>
                  <p>
                     <graphic xlink:href="2702-web-resources/image/zdravvestn-2702-sl-04.jpg"/>
                  </p>
               </fig>
            </sec>
            <sec id="s3.3.4" sec-type="Sistem za podporo pri kliničnem odločanju">
               <label>3.3.4</label>
               <title>Sistem za podporo pri kliničnem odločanju</title>
               <p>V aplikacijo za izvajalce zdravstvene dejavnosti je vključen sistem za podporo pri kliničnem odločanju MASK CDSS. Gre za algoritem, ki zdravniku na podlagi VAS pomaga pri smiselni izbiri zdravil za bolnike z AR in pri stratifikaciji bolnikov glede na resnost njihove bolezni (<xref ref-type="bibr" rid="b27">27</xref>). Uporablja preprost individualiziran pristop k zdravljenju AR s povečevanjem oz. zmanjševanjem odmerkov.</p>
            </sec>
         </sec>
      </sec>
      <sec id="s4"
           sec-type="Novi koncepti alergijske več obolevnosti, vključeni v ARIA">
         <label>4</label>
         <title>Novi koncepti alergijske več obolevnosti, vključeni v ARIA</title>
         <sec id="s4.1"
              sec-type="Stratifikacija bolnikov s težjimi oblikami alergije in/ali astme">
            <label>4.1</label>
            <title>Stratifikacija bolnikov s težjimi oblikami alergije in/ali astme</title>
            <p>Kljub velikemu napredku pri razumevanju AR zdravljenje pri vseh bolnikih še vedno ni učinkovito (<xref ref-type="bibr" rid="b31">31</xref>). S pomočjo orodja MASK se želijo zagotoviti učinkovitejši terapevtski ukrepi, ki bi se prilagodili posamezniku.</p>
            <p>Dolgoročne študije t. i. rojstnih kohort so izjemno pomembne za razumevanje poteka alergijskih bolezni (vključno z astmo in rinitisom) ter zapletenega medsebojnega odnosa med geni in okoljem (<xref ref-type="bibr" rid="b32">32</xref>). Rojstne kohorte so dolgoročne študije, v katere se ob rojstvu vključijo otroci z določenega območja, ki jih nato spremljajo med odraščanjem. Nekatere kohorte so vključevale tudi spremljanje še v odrasli dobi. V zadnjih tridesetih letih so na svetu začeli več kot 100 študij rojstnih kohort, ki so se osredinjale na astmo in alergijske bolezni. Združevanje podatkov iz več študij rojstnih kohort omogoča med drugim tudi večjo statistično moč pri opredelitvi dejavnikov, ki vplivajo na potek alergijskih bolezni (<xref ref-type="bibr" rid="b32">32</xref>). Projekta BAMSE (Barn Allergi Milj Stockholm Epidemiologi Projektet) (<xref ref-type="bibr" rid="b33">33</xref>) in MeDALL (Mechanisms of Development of ALLergy, European Union Framework Programme 7, projekt št. 261357; 2010–2015) (<xref ref-type="bibr" rid="b34">34</xref>) sta opredelila redek fenotip, ki je nagnjen k težjim oblikam alergijskih bolezni: polisenzibiliziran-multimorbidni fenotip, ki je bil potrjen v kohortah bolnikov pri otrocih in odraslih (<xref ref-type="bibr" rid="b35">35</xref>-<xref ref-type="bibr" rid="b38">38</xref>). Te študije in oba projekta potrjujejo, da imajo polisenzibilizirane in osebe z več boleznimi zelo visoko pogostnost alergijskih simptomov, trajne simptome, več težjih simptomov astme in rinitisa ter višje vrednosti celokupnih in specifičnih protiteles IgE kot drugi fenotipi.</p>
            <p>Navedeni rezultati potrjujejo, da bolniki z astmo ne morejo biti optimalno zdravljeni brez upoštevanja pridruženega rinitisa. Iz rezultatov je razvidno, kako pomembne so bolezni nosu (rinitis in/ali rinosinusitis) pri številnih bolnikih z neurejeno astmo (<xref ref-type="bibr" rid="b39">39</xref>,<xref ref-type="bibr" rid="b40">40</xref>).</p>
         </sec>
         <sec id="s4.2" sec-type="Alergijska več obolevnost pri starejših">
            <label>4.2</label>
            <title>Alergijska več obolevnost pri starejših</title>
            <p>Doslej je bilo premalo pozornosti namenjene pričakovanemu valu epidemije astme in rinitisa pri starejših odraslih, ki imajo specifične simptome in potrebe po zdravljenju. Ti bolniki imajo pogosteje pridružene bolezni in prejemajo več vrst zdravil. Integrirane klinične poti za rinitis in astmo morajo zajemati ves življenjski krog.</p>
         </sec>
      </sec>
      <sec id="s5"
           sec-type="Strategija rasti in razširitve AIRWAYs ICP v Sloveniji">
         <label>5</label>
         <title>Strategija rasti in razširitve AIRWAYs ICP v Sloveniji</title>
         <p>Strategije rasti in razširitve so izjemno pomembne, saj omogočajo: 1. izogibanje razdrobljenosti, 2. izboljšanje zagotavljanja zdravstvenih storitev po Evropi, 3. pospešitev uvajanja dobrih praks z uporabo obstoječih stroškovno učinkovitih modelov in 4. izpolnjevanje ciljev EIP on AHA (<xref ref-type="bibr" rid="b9">9</xref>). Strategijo rasti in razširitve AIRWAYs ICP<italic> </italic>so že uporabili pri akcijskem načrtu EIP on AHA za kronične bolezni dihal (<xref ref-type="bibr" rid="b12">12</xref>).</p>
         <p>V Sloveniji načrtujemo prevod aplikacij »alergijski dnevnik ARIA« za bolnike in »spremljevalec alergijskega dnevnika ARIA« za zdravstvene delavce, ki za zdaj pri nas še nista na voljo. Poleg tega želimo prilagoditi smernice pobude ARIA za lokalne razmere in jih združiti s smernicami za obravnavo nealergijskega rinitisa. Oblikovali smo delovno skupino, ki vključuje zdravnike primarnega zdravstva, specialiste alergologe in pulmologe, specialiste otorinolaringologe, pediatre in lekarniške farmacevte, ki svetujejo pri samozdravljenju rinitisa in pri tem upoštevajo preverjene metode zdravljenja.</p>
      </sec>
      <sec id="s6" sec-type="Zaključek">
         <label>6</label>
         <title>Zaključek</title>
         <p>Pobuda ARIA se je iz natančno začrtanih smernic razvila v t. i. implementacijsko strategijo, ki temelji na mobilni tehnologiji. Njena namena sta zagotavljanje aktivnega in zdravega življenja bolnikom z rinitisom ne glede na njihovo starost, spol ali družbeno-gospodarski položaj ter zmanjševanje zdravstvene in družbene neenakosti, ki ju globalno povzroča ta zelo pogosta bolezen.</p>
      </sec>
      <sec id="s7" sec-type="Financiranje">
         <label>7</label>
         <title>Financiranje</title>
         <p>Članek je nastal v okviru projekta, ki ga je financiralo »Evropsko partnerstvo za inovacije za aktivno in zdravo staranje«.</p>
      </sec>
      <sec id="s8" sec-type="Referenčna stran">
         <label>8</label>
         <title>Referenčna stran</title>
         <p>MACVIA, Francija, EU-strukturni in razvojni sklad Languedoc-Roussillon, ARIA</p>
      </sec>
   </body>
   <back>
      <ref-list>
         <ref id="b1">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Shekelle</surname>
                     <given-names>PG</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Woolf</surname>
                     <given-names>SH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eccles</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Grimshaw</surname>
                     <given-names>J</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Clinical guidelines: developing guidelines</article-title>. 
                    <source>BMJ</source>. 
                    <year>1999</year>
                    <month>Feb</month>;
                    <volume>318</volume>(
                    <issue>7183</issue>):
                    <fpage>593</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/bmj.318.7183.593</pub-id>
                    <pub-id pub-id-type="pmid">10037645</pub-id>
                    <issn>0959-8138</issn>
                </mixed-citation>
         </ref>
         <ref id="b2">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Van Cauwenberge</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khaltaev</surname>
                     <given-names>N</given-names>
                  </name>; 
                        <collab>Aria Workshop Group</collab>; 
                        <collab>World Health Organization</collab>
                    </person-group>. 
                    <article-title>Allergic rhinitis and its impact on asthma</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2001</year>
                    <month>Nov</month>;
                    <volume>108</volume>(
                    <issue>5</issue>
                    <supplement>Suppl</supplement>):
                    <fpage>S147</fpage>–
                    <lpage>334</lpage>. 
                    <pub-id pub-id-type="doi">10.1067/mai.2001.118891</pub-id>
                    <pub-id pub-id-type="pmid">11707753</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b3">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khaltaev</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cruz</surname>
                     <given-names>AA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Denburg</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fokkens</surname>
                     <given-names>WJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Togias</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>AllerGen</collab>
                    </person-group>. 
                    <article-title>Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)</article-title>. 
                    <source>Allergy</source>. 
                    <year>2008</year>
                    <month>Apr</month>;
                    <volume>63</volume>
                    <supplement>Suppl 86</supplement>:
                    <fpage>8</fpage>–
                    <lpage>160</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1398-9995.2007.01620.x</pub-id>
                    <pub-id pub-id-type="pmid">18331513</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b4">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Brozek</surname>
                     <given-names>JL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Baena-Cagnani</surname>
                     <given-names>CE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bonini</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Canonica</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Casale</surname>
                     <given-names>TB</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>Global Allergy and Asthma European Network</collab>; 
                        <collab>Grading of Recommendations Assessment, Development and Evaluation Working Group</collab>
                    </person-group>. 
                    <article-title>Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2010</year>
                    <month>Sep</month>;
                    <volume>126</volume>(
                    <issue>3</issue>):
                    <fpage>466</fpage>–
                    <lpage>76</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2010.06.047</pub-id>
                    <pub-id pub-id-type="pmid">20816182</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b5">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Padjas</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kehar</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Aleem</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mejza</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schunemann</surname>
                     <given-names>HJ</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>. 
                    <article-title>Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2014</year>;
                    <month>Apr</month>;
                    <volume>133</volume>
                    <issue>3</issue>:
                    <fpage>777</fpage>–
                    <lpage>84.e4</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2013.08.029</pub-id>
                    <pub-id pub-id-type="pmid">24139606</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b6">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schünemann</surname>
                     <given-names>HJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Samolinski</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Baena-Cagnani</surname>
                     <given-names>CE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>World Health Organization Collaborating Center for Asthma and Rhinitis</collab>
                    </person-group>. 
                    <article-title>Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2012</year>
                    <month>Nov</month>;
                    <volume>130</volume>(
                    <issue>5</issue>):
                    <fpage>1049</fpage>–
                    <lpage>62</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2012.07.053</pub-id>
                    <pub-id pub-id-type="pmid">23040884</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b7">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Addis</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Adcock</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Agache</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Agusti</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Alonso</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>European Innovation Partnership on Active and Healthy Ageing, Action Plan B3</collab>; 
                        <collab>Mechanisms of the Development of Allergy, WP 10</collab>; 
                        <collab>Global Alliance against Chronic Respiratory Diseases</collab>
                    </person-group>. 
                    <article-title>Integrated care pathways for airway diseases (AIRWAYS-ICPs)</article-title>. 
                    <source>Eur Respir J</source>. 
                    <year>2014</year>
                    <month>Aug</month>;
                    <volume>44</volume>(
                    <issue>2</issue>):
                    <fpage>304</fpage>–
                    <lpage>23</lpage>. 
                    <pub-id pub-id-type="doi">10.1183/09031936.00014614</pub-id>
                    <pub-id pub-id-type="pmid">24925919</pub-id>
                    <issn>0903-1936</issn>
                </mixed-citation>
         </ref>
         <ref id="b8">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hellings</surname>
                     <given-names>PW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Agache</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bedbrook</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bergmann</surname>
                     <given-names>KC</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle</article-title>. 
                    <source>Clin Transl Allergy</source>. 
                    <year>2016</year>
                    <month>Dec</month>;
                    <volume>6</volume>(
                    <issue>1</issue>):
                    <fpage>47</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s13601-016-0137-4</pub-id>
                    <pub-id pub-id-type="pmid">28050247</pub-id>
                    <issn>2045-7022</issn>
                </mixed-citation>
         </ref>
         <ref id="b9">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Michel</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Standberg</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Crooks</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Iakovidis</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gomez</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The European Innovation Partnership on Active and Healthy Ageing: the European Geriatric Medicine introduces the EIP on AHA Column</article-title>. 
                    <source>Eur Geriatr Med</source>. 
                    <year>2014</year>;
                    <volume>5</volume>(
                    <issue>6</issue>):
                    <fpage>361</fpage>–
                    <lpage>2</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.eurger.2014.09.010</pub-id>
                    <issn>1878-7649</issn>
                </mixed-citation>
         </ref>
         <ref id="b10">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anto</surname>
                     <given-names>JM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Berkouk</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gergen</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Antunes</surname>
                     <given-names>JP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Augé</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Developmental determinants in non-communicable chronic diseases and ageing</article-title>. 
                    <source>Thorax</source>. 
                    <year>2015</year>
                    <month>Jun</month>;
                    <volume>70</volume>(
                    <issue>6</issue>):
                    <fpage>595</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/thoraxjnl-2014-206304</pub-id>
                    <pub-id pub-id-type="pmid">25616486</pub-id>
                    <issn>0040-6376</issn>
                </mixed-citation>
         </ref>
         <ref id="b11">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Barbara</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bateman</surname>
                     <given-names>E</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bel</surname>
                     <given-names>E</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chavannes</surname>
                     <given-names>NH</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>AIRWAYS-ICPs working group</collab>
                    </person-group>. 
                    <article-title>AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation</article-title>. 
                    <source>Eur Respir J</source>. 
                    <year>2016</year>
                    <month>Apr</month>;
                    <volume>47</volume>(
                    <issue>4</issue>):
                    <fpage>1028</fpage>–
                    <lpage>33</lpage>. 
                    <pub-id pub-id-type="doi">10.1183/13993003.01856-2015</pub-id>
                    <pub-id pub-id-type="pmid">27037308</pub-id>
                    <issn>0903-1936</issn>
                </mixed-citation>
         </ref>
         <ref id="b12">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Farrell</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Crooks</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hellings</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bel</surname>
                     <given-names>EH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)</article-title>. 
                    <source>Clin Transl Allergy</source>. 
                    <year>2016</year>
                    <month>Jul</month>;
                    <volume>6</volume>(
                    <issue>1</issue>):
                    <fpage>29</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s13601-016-0116-9</pub-id>
                    <pub-id pub-id-type="pmid">27478588</pub-id>
                    <issn>2045-7022</issn>
                </mixed-citation>
         </ref>
         <ref id="b13">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cano</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eklund</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fico</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Goswami</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA</article-title>. 
                    <source>J Nutr Health Aging</source>. 
                    <year>2017</year>;
                    <volume>21</volume>(
                    <issue>1</issue>):
                    <fpage>92</fpage>–
                    <lpage>104</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s12603-016-0803-1</pub-id>
                    <pub-id pub-id-type="pmid">27999855</pub-id>
                    <issn>1279-7707</issn>
                </mixed-citation>
         </ref>
         <ref id="b14">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Kuehl</surname>
                     <given-names>BL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Abdulnour</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>O’Dell</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kyle</surname>
                     <given-names>TK</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Understanding the role of the healthcare professional in patient self-management of allergic rhinitis</article-title>. 
                    <source>SAGE Open Med</source>. 
                    <year>2015</year>
                    <month>Aug</month>;
                    <volume>3</volume>:
                    <fpage>2050312115595822</fpage>. 
                    <pub-id pub-id-type="doi">10.1177/2050312115595822</pub-id>
                    <pub-id pub-id-type="pmid">26770793</pub-id>
                    <issn>2050-3121</issn>
                </mixed-citation>
         </ref>
         <ref id="b15">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>van Cauwenberge</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khaltaev</surname>
                     <given-names>N</given-names>
                  </name>; 
                        <collab>Members of the Workshops</collab>
                    </person-group>. 
                    <article-title>ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma</article-title>. 
                    <source>Allergy</source>. 
                    <year>2004</year>
                    <month>Apr</month>;
                    <volume>59</volume>(
                    <issue>4</issue>):
                    <fpage>373</fpage>–
                    <lpage>87</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1398-9995.2003.00468.x</pub-id>
                    <pub-id pub-id-type="pmid">15005760</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b16">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Canonica</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Triggiani</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Senna</surname>
                     <given-names>G</given-names>
                  </name>
                    </person-group>. 
                    <article-title>360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients</article-title>. 
                    <source>Clin Mol Allergy</source>. 
                    <year>2015</year>
                    <month>Nov</month>;
                    <volume>13</volume>(
                    <issue>1</issue>):
                    <fpage>25</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s12948-015-0029-5</pub-id>
                    <pub-id pub-id-type="pmid">26528081</pub-id>
                    <issn>1476-7961</issn>
                </mixed-citation>
         </ref>
         <ref id="b17">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Meltzer</surname>
                     <given-names>EO</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Farrar</surname>
                     <given-names>JR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sennett</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients</article-title>. 
                    <source>J Allergy Clin Immunol Pract</source>. 
                    <year>2017</year>                    
                    <month>May</month>;
                    <volume>5</volume>(
                    <issue>3</issue>):
                    <fpage>779</fpage>-
                    <lpage>89.e6</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.jaip.2016.10.010</pub-id>
                    <pub-id pub-id-type="pmid">27914815</pub-id>
                    <issn>2213-2198</issn>
                </mixed-citation>
         </ref>
         <ref id="b18">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Annesi-Maesano</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Carat</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Léger</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rugina</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pribil</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group</article-title>. 
                    <source>Clin Exp Allergy</source>. 
                    <year>2005</year>
                    <month>Jun</month>;
                    <volume>35</volume>(
                    <issue>6</issue>):
                    <fpage>728</fpage>–
                    <lpage>32</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1365-2222.2005.02274.x</pub-id>
                    <pub-id pub-id-type="pmid">15969662</pub-id>
                    <issn>0954-7894</issn>
                </mixed-citation>
         </ref>
         <ref id="b19">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>PJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Devillier</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tadmouri</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mesbah</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study</article-title>. 
                    <source>Int Arch Allergy Immunol</source>. 
                    <year>2015</year>;
                    <volume>166</volume>(
                    <issue>3</issue>):
                    <fpage>231</fpage>–
                    <lpage>40</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000381339</pub-id>
                    <pub-id pub-id-type="pmid">25924687</pub-id>
                    <issn>1018-2438</issn>
                </mixed-citation>
         </ref>
         <ref id="b20">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>del Cuvillo</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Montoro</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bartra</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Valero</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ferrer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Jauregui</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study</article-title>. 
                    <source>Rhinology</source>. 
                    <year>2010</year>
                    <month>Jun</month>;
                    <volume>48</volume>(
                    <issue>2</issue>):
                    <fpage>201</fpage>–
                    <lpage>5</lpage>. 
                    <pub-id pub-id-type="doi">10.4193/Rhin09.099</pub-id>
                    <pub-id pub-id-type="pmid">20502761</pub-id>
                    <issn>0300-0729</issn>
                </mixed-citation>
         </ref>
         <ref id="b21">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Calderon</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Casale</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Akdis</surname>
                     <given-names>CA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project</article-title>. 
                    <source>Clin Transl Allergy</source>. 
                    <year>2016</year>
                    <month>Nov</month>;
                    <volume>6</volume>(
                    <issue>1</issue>):
                    <fpage>41</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s13601-016-0131-x</pub-id>
                    <pub-id pub-id-type="pmid">27895895</pub-id>
                    <issn>2045-7022</issn>
                </mixed-citation>
         </ref>
         <ref id="b22">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Cruz</surname>
                     <given-names>AA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Popov</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pawankar</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Annesi-Maesano</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fokkens</surname>
                     <given-names>W</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kemp</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>ARIA Initiative Scientific Committee</collab>
                    </person-group>. 
                    <article-title>Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN</article-title>. 
                    <source>Allergy</source>. 
                    <year>2007</year>;
                    <volume>62</volume>(
                    <issue>s84</issue>
                    <supplement>Suppl 84</supplement>):
                    <fpage>1</fpage>–
                    <lpage>41</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1398-9995.2007.01551.x</pub-id>
                    <pub-id pub-id-type="pmid">17924930</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b23">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>PJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Devillier</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tadmouri</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mesbah</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study</article-title>. 
                    <source>Int Arch Allergy Immunol</source>. 
                    <year>2015</year>;
                    <volume>166</volume>(
                    <issue>3</issue>):
                    <fpage>231</fpage>–
                    <lpage>40</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000381339</pub-id>
                    <pub-id pub-id-type="pmid">25924687</pub-id>
                    <issn>1018-2438</issn>
                </mixed-citation>
         </ref>
         <ref id="b24">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Meltzer</surname>
                     <given-names>EO</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wallace</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Dykewicz</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Shneyer</surname>
                     <given-names>L</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?</article-title> 
                    <source>J Allergy Clin Immunol Pract</source>. 
                    <year>2016</year>;
                    <month>Jul-Aug</month>;
                    <volume>4</volume>(
                    <issue>4</issue>):
                    <fpage>682</fpage>–
                    <lpage>8.e6</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaip.2016.02.006</pub-id>
                    <pub-id pub-id-type="pmid">27084419</pub-id>
                </mixed-citation>
         </ref>
         <ref id="b25">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schunemann</surname>
                     <given-names>HJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fonseca</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Samolinski</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Canonica</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation</article-title>. 
                    <source>Allergy</source>. 
                    <year>2015</year>
                    <month>Nov</month>;
                    <volume>70</volume>(
                    <issue>11</issue>):
                    <fpage>1372</fpage>–
                    <lpage>92</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/all.12686</pub-id>
                    <pub-id pub-id-type="pmid">26148220</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b26">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bourret</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mercier</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Camuzat</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bedbrook</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis</article-title>. 
                    <source>World Hosp Health Serv</source>. 
                    <year>2015</year>;
                    <volume>51</volume>(
                    <issue>3</issue>):
                    <fpage>36</fpage>–
                    <lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">26571642</pub-id>
                    <issn>1029-0540</issn>
                </mixed-citation>
         </ref>
         <ref id="b27">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schunemann</surname>
                     <given-names>HJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hellings</surname>
                     <given-names>PW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Arnavielhe</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bedbrook</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2016</year> 
                    <month>May-Jun</month>;
                    <volume>138</volume>(
                    <issue>2</issue>):
                    <fpage>367</fpage>–
                    <lpage>74.e2</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaip.2016.10.010</pub-id>
                    <pub-id pub-id-type="pmid">27914815</pub-id>
                    <issn>2213-2198</issn>
                </mixed-citation>
         </ref>
         <ref id="b28">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Caimmi</surname>
                     <given-names>DP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bedbrook</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hellings</surname>
                     <given-names>PW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Devillier</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study</article-title>. 
                    <source>Allergy</source>. 
                    <year>2017</year>
                    <month>Jun</month>;
                    <volume>72</volume>(
                    <issue>6</issue>):
                    <fpage>857</fpage>–
                    <lpage>65</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/all.13125</pub-id>
                    <pub-id pub-id-type="pmid">28072463</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b29">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>König</surname>
                     <given-names>HH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bernert</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Angermeyer</surname>
                     <given-names>MC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Matschinger</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Martinez</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vilagut</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>ESEMeD/MHEDEA 2000 Investigators</collab>
                    </person-group>. 
                    <article-title>Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire</article-title>. 
                    <source>Med Care</source>. 
                    <year>2009</year>
                    <month>Feb</month>;
                    <volume>47</volume>(
                    <issue>2</issue>):
                    <fpage>255</fpage>–
                    <lpage>61</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/MLR.0b013e318184759e</pub-id>
                    <pub-id pub-id-type="pmid">19169128</pub-id>
                    <issn>0025-7079</issn>
                </mixed-citation>
         </ref>
         <ref id="b30">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Blanc</surname>
                     <given-names>PD</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Trupin</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eisner</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Earnest</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Katz</surname>
                     <given-names>PP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Israel</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The work impact of asthma and rhinitis: findings from a population-based survey</article-title>. 
                    <source>J Clin Epidemiol</source>. 
                    <year>2001</year>
                    <month>Jun</month>;
                    <volume>54</volume>(
                    <issue>6</issue>):
                    <fpage>610</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0895-4356(00)00349-8</pub-id>
                    <pub-id pub-id-type="pmid">11377122</pub-id>
                    <issn>0895-4356</issn>
                </mixed-citation>
         </ref>
         <ref id="b31">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Canonica</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Casale</surname>
                     <given-names>TB</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cruz</surname>
                     <given-names>AA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lockey</surname>
                     <given-names>RJ</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>Extended Global Allergy and Asthma European Network, World Allergy Organization and Allergic Rhinitis and its Impact on Asthma Study Group</collab>
                    </person-group>. 
                    <article-title>Unmet needs in severe chronic upper airway disease (SCUAD)</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2009</year>
                    <month>Sep</month>;
                    <volume>124</volume>(
                    <issue>3</issue>):
                    <fpage>428</fpage>–
                    <lpage>33</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2009.06.027</pub-id>
                    <pub-id pub-id-type="pmid">19660803</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b32">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anto</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sunyer</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Nieuwenhuijsen</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vrijheid</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Keil</surname>
                     <given-names>T</given-names>
                  </name>; 
                        <collab>MeDALL Study Group</collab>; 
                        <collab>CHICOS Study Group</collab>; 
                        <collab>ENRIECO Study Group</collab>; 
                        <collab>GA²LEN Study Group</collab>
                    </person-group>. 
                    <article-title>Pooling birth cohorts in allergy and asthma: european Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper</article-title>. 
                    <source>Int Arch Allergy Immunol</source>. 
                    <year>2013</year>;
                    <volume>161</volume>(
                    <issue>1</issue>):
                    <fpage>1</fpage>–
                    <lpage>10</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000343018</pub-id>
                    <pub-id pub-id-type="pmid">23258290</pub-id>
                    <issn>1018-2438</issn>
                </mixed-citation>
         </ref>
         <ref id="b33">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Westman</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lupinek</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Andersson</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pahr</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Baar</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2015</year>
                    <month>May</month>;
                    <volume>135</volume>(
                    <issue>5</issue>):
                    <fpage>1199</fpage>–
                    <lpage>106.e1-11</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2014.10.042</pub-id>
                    <pub-id pub-id-type="pmid">25528361</pub-id>
                    <issn>0091-6749</issn>                    
                </mixed-citation>
         </ref>
         <ref id="b34">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anto</surname>
                     <given-names>JM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Akdis</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Auffray</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Keil</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Momas</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015</article-title>. 
                    <source>Allergy</source>. 
                    <year>2016</year>
                    <month>Nov</month>;
                    <volume>71</volume>(
                    <issue>11</issue>):
                    <fpage>1513</fpage>–
                    <lpage>25</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/all.12880</pub-id>
                    <pub-id pub-id-type="pmid">26970340</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b35">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Burte</surname>
                     <given-names>E</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Varraso</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gormand</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Just</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Matran</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Characterization of Rhinitis According to the Asthma Status in Adults Using an Unsupervised Approach in the EGEA Study</article-title>. 
                    <source>PLoS One</source>. 
                    <year>2015</year>
                    <month>Aug</month>;
                    <volume>10</volume>(
                    <issue>8</issue>):
                    <fpage>e0136191</fpage>. 
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0136191</pub-id>
                    <pub-id pub-id-type="pmid">26309034</pub-id>
                    <issn>1932-6203</issn>
                </mixed-citation>
         </ref>
         <ref id="b36">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Siroux</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lupinek</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Resch</surname>
                     <given-names>Y</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Curin</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Just</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Keil</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: the EGEA study</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2017</year> 
                    <month>Feb</month>;
                    <volume>139</volume>(
                    <issue>2</issue>):
                    <fpage>643</fpage>. 
                    <lpage>654.e6</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2016.05.023</pub-id>
                    <pub-id pub-id-type="pmid">27464960</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b37">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Just</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Elegbede</surname>
                     <given-names>CF</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Deschildre</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Moneret-Vautrin</surname>
                     <given-names>DA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Crepet</surname>
                     <given-names>A</given-names>
                  </name>; 
                        <collab>Mirabel study group</collab>
                    </person-group>. 
                    <article-title>Three peanut-allergic/sensitized phenotypes with gender difference</article-title>. 
                    <source>Clin Exp Allergy</source>. 
                    <year>2016</year>
                    <month>Dec</month>;
                    <volume>46</volume>(
                    <issue>12</issue>):
                    <fpage>1596</fpage>–
                    <lpage>604</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/cea.12791</pub-id>
                    <pub-id pub-id-type="pmid">27512923</pub-id>
                    <issn>0954-7894</issn>
                </mixed-citation>
         </ref>
         <ref id="b38">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Zoratti</surname>
                     <given-names>EM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Krouse</surname>
                     <given-names>RZ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Babineau</surname>
                     <given-names>DC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pongracic</surname>
                     <given-names>JA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>O’Connor</surname>
                     <given-names>GT</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wood</surname>
                     <given-names>RA</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Asthma phenotypes in inner-city children</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2016</year>
                    <month>Oct</month>;
                    <volume>138</volume>(
                    <issue>4</issue>):
                    <fpage>1016</fpage>–
                    <lpage>29</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2016.06.061</pub-id>
                    <pub-id pub-id-type="pmid">27720016</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b39">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bresciani</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Paradis</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Des Roches</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vernhet</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vachier</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Godard</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Rhinosinusitis in severe asthma</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2001</year>
                    <month>Jan</month>;
                    <volume>107</volume>(
                    <issue>1</issue>):
                    <fpage>73</fpage>–
                    <lpage>80</lpage>. 
                    <pub-id pub-id-type="doi">10.1067/mai.2001.111593</pub-id>
                    <pub-id pub-id-type="pmid">11149994</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b40">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>ten Brinke</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Grootendorst</surname>
                     <given-names>DC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schmidt</surname>
                     <given-names>JT</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>De Bruïne</surname>
                     <given-names>FT</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>van Buchem</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sterk</surname>
                     <given-names>PJ</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Chronic sinusitis in severe asthma is related to sputum eosinophilia</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2002</year>
                    <month>Apr</month>;
                    <volume>109</volume>(
                    <issue>4</issue>):
                    <fpage>621</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1067/mai.2002.122458</pub-id>
                    <pub-id pub-id-type="pmid">11941310</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
